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Correspondence 371chose not to reference the article, despite its high calibre.
Ratcliffe et al. have shown sustained benefits following
a supervised exercise programme, but this work offers no
direct insight into the value of unsupervised exercise.3
There is always pressure to keep manuscripts succinct
and as directly relevant as possible, yet set out in context
of the subject as a whole. We believe our manuscript
achieves this. The journal is important and has a good
impact factor. However, the impact factor is not our
concern. We have focused purely on how to relate our
work, in context, to the readership.
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Sir,
The DEFINE group’s initiative deserves credit for bringing the
patient’sperspectiveandoutcomemeasuresbeyondtechnical
success to the attention of an expanding team of health-care
professionals involved in the treatment of peripheral arterial
disease (PAD) patients. However, the urge for the initiative,
theaimto take intoaccount thepatient’s perspective, and the
absence of criteria on which the proposed definitions are
based give rise to some questions and remarks.
The DEFINE initiative suggests that the characteristics
and outcome measures for patients who are treated by
endovascular means differ from those for patients who aretreated otherwise. However, baseline characteristics and
outcome measures depend on patients, irrespective of
treatment modality or the specialities that aim to treat PAD
patients. The DEFINE group’s proposals largely consist of
a synopsis of SVS/ISCVS1 and TASC II2 recommendations. In
our opinion, incorporation of endovascular refinements in
the existing guidelines might prevent the impending
confusion on this topic, as noticed by the authors, rather
than adding a new set of proposals.
In line with the existing recommendations, the DEFINE
initiative advocates special attention for the patient’s
perspective and proposes to supplement baseline charac-
teristics and outcome measures with functional status,
walking ability and quality of life (QoL).
With respect to QoL, a conceptual error of thinking
has been made by recommending the EuroQol as a
measure. The EuroQol is a measure of health status
developed for use in combination with other measures.3
Health status is not identical to, or exchangeable with,
QoL. The risks of presenting health status data as QoL have
been brought forward in other publications.4 Moreover,
even if the authors want to restrict the patient’s perspec-
tive to health status alone, it is remarkable to propose the
EuroQol out of a plethora of measures, without presenting
the considerations or criteria to support this choice.
The proposed definitionswould reflect a real consensus and
be more relevant when incorporated in the existing recom-
mendations, disclosing the criteria on which the proposals
were made and addressing patients’ values appropriately.
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